Proteomics Intl Labs Ltd has released a press release.
December 2020 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- AGM Investor Presentation
- Middle East is next market for PromarkerD immunoassay test
- PromarkerD clinical assay performance results published
- Proteomics receives $1.1 million in R&D tax incentive
- Completion of Placement and Appendix 2A
Later from Proteomics International Laboratories
- Proteomics International seeks FDA approval for PromarkerD
- Response to Price Query
- ISO 13485 certification received - Manufacturing Update
- March 2021 Quarterly Activities Report and Appendix 4C
- Major economic health benefit demonstrated for PromarkerD
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories